As of 2025-11-09, the Relative Valuation of Silverback Therapeutics Inc (SBTX) is (22.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.87 USD, the upside of Silverback Therapeutics Inc based on Relative Valuation is -476.0%.
The range of the Relative Valuation is (18.60) - (23.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 23.9x | 20.8x |
| Forward P/E multiples | 19.3x - 30.9x | 25.1x |
| Fair Price | (18.60) - (23.01) | (22.07) |
| Upside | -416.9% - -491.9% | -476.0% |
| Date | P/E |